Faculty Opinions recommendation of CD8 T cell competition for dendritic cells in vivo is an early event in activation.

Author(s):  
Andrea Sant
2006 ◽  
Vol 103 (32) ◽  
pp. 12063-12068 ◽  
Author(s):  
R. A. Willis ◽  
J. W. Kappler ◽  
P. C. Marrack

Immunity ◽  
2006 ◽  
Vol 24 (2) ◽  
pp. 191-201 ◽  
Author(s):  
Marie Le Borgne ◽  
Nathalie Etchart ◽  
Anne Goubier ◽  
Sergio A. Lira ◽  
Jean Claude Sirard ◽  
...  

2008 ◽  
Vol 181 (6) ◽  
pp. 3811-3817 ◽  
Author(s):  
Pia Björck ◽  
Andreas Beilhack ◽  
Edward I. Herman ◽  
Robert S. Negrin ◽  
Edgar G. Engleman

Blood ◽  
2008 ◽  
Vol 112 (9) ◽  
pp. 3713-3722 ◽  
Author(s):  
Juliette Mouriès ◽  
Gabriel Moron ◽  
Géraldine Schlecht ◽  
Nicolas Escriou ◽  
Gilles Dadaglio ◽  
...  

Abstract Cross-presentation is a crucial mechanism in tumoral and microbial immunity because it allows internalized cell associated or exogenous antigens (Ags) to be delivered into the major histocompatibility complex I pathway. This pathway is important for the development of CD8+ T-cell responses and for the induction of tolerance. In mice, cross-presentation is considered to be a unique property of CD8α+ conventional dendritic cells (DCs). Here we show that splenic plasmacytoid DCs (pDCs) efficiently capture exogenous Ags in vivo but are not able to cross-present these Ags at steady state. However, in vitro and in vivo stimulation by Toll-like receptor-7, or -9 or viruses licenses pDCs to cross-present soluble or particulate Ags by a transporter associated with antigen processing-dependent mechanism. Induction of cross-presentation confers to pDCs the ability to generate efficient effector CD8+ T-cell responses against exogenous Ags in vivo, showing that pDCs may play a crucial role in induction of adaptive immune responses against pathogens that do not infect tissues of hemopoietic origin. This study provides the first evidence for an in vivo role of splenic pDCs in Ag cross-presentation and T-cell cross-priming and suggests that pDCs may constitute an attractive target to boost the efficacy of vaccines based on cytotoxic T lymphocyte induction.


2000 ◽  
Vol 165 (9) ◽  
pp. 4994-5003 ◽  
Author(s):  
Gilles Foucras ◽  
Jérôme D. Coudert ◽  
Christiane Coureau ◽  
Jean-Charles Guéry

2015 ◽  
Vol 213 (1) ◽  
pp. 75-92 ◽  
Author(s):  
Yannick O. Alexandre ◽  
Sonia Ghilas ◽  
Cindy Sanchez ◽  
Agnès Le Bon ◽  
Karine Crozat ◽  
...  

Naive CD8+ T cell priming during tumor development or many primary infections requires cross-presentation by XCR1+ dendritic cells (DCs). Memory CD8+ T lymphocytes (mCTLs) harbor a lower activation threshold as compared with naive cells. However, whether their recall responses depend on XCR1+ DCs is unknown. By using a new mouse model allowing fluorescent tracking and conditional depletion of XCR1+ DCs, we demonstrate a differential requirement of these cells for mCTL recall during secondary infections by different pathogens. XCR1+ DCs were instrumental to promote this function upon secondary challenges with Listeria monocytogenes, vesicular stomatitis virus, or Vaccinia virus, but dispensable in the case of mouse cytomegalovirus. We deciphered how XCR1+ DCs promote mCTL recall upon secondary infections with Listeria. By visualizing for the first time the in vivo choreography of XCR1+ DCs, NK cells and mCTLs during secondary immune responses, and by neutralizing in vivo candidate molecules, we demonstrate that, very early after infection, mCTLs are activated, and attracted in a CXCR3-dependent manner, by NK cell–boosted, IL-12–, and CXCL9-producing XCR1+ DCs. Hence, depending on the infectious agent, strong recall of mCTLs during secondary challenges can require cytokine- and chemokine-dependent cross-talk with XCR1+ DCs and NK cells.


Vaccine ◽  
2004 ◽  
Vol 23 (5) ◽  
pp. 604-614 ◽  
Author(s):  
Catherine Fayolle ◽  
Cécile Bauche ◽  
Daniel Ladant ◽  
Claude Leclerc

Sign in / Sign up

Export Citation Format

Share Document